Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

J Clin Oncol. 2007 Apr 10;25(11):1447-8; author reply 1448. doi: 10.1200/JCO.2006.09.9713.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma / drug therapy
  • Carcinoma / metabolism*
  • Disease Progression
  • Erythropoietin / adverse effects*
  • Erythropoietin / therapeutic use
  • Female
  • Gene Expression Profiling
  • Head and Neck Neoplasms / drug therapy
  • Head and Neck Neoplasms / metabolism*
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Receptors, Erythropoietin / metabolism*
  • Recombinant Proteins
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome

Substances

  • Receptors, Erythropoietin
  • Recombinant Proteins
  • epoetin beta
  • Erythropoietin